FJ, M., M, W., M, G., C, H., A, B., F, A., . . . CE, C. (2024). PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial. NPJ vaccines, 9(1), 10. https://doi.org/10.1038/s41541-023-00796-7
Chicago Style (17th ed.) CitationFJ, Martinez, et al. "PvDBPII Elicits Multiple Antibody-mediated Mechanisms That Reduce Growth in a Plasmodium Vivax Challenge Trial." NPJ Vaccines 9, no. 1 (2024): 10. https://doi.org/10.1038/s41541-023-00796-7.
MLA (9th ed.) CitationFJ, Martinez, et al. "PvDBPII Elicits Multiple Antibody-mediated Mechanisms That Reduce Growth in a Plasmodium Vivax Challenge Trial." NPJ Vaccines, vol. 9, no. 1, 2024, p. 10, https://doi.org/10.1038/s41541-023-00796-7.
Warning: These citations may not always be 100% accurate.